NYSE American - Delayed Quote USD

Retractable Technologies, Inc. (RVP)

0.7110
-0.0389
(-5.19%)
At close: 4:00:00 PM EDT
0.7300
+0.02
+(2.67%)
After hours: 5:44:08 PM EDT
Loading Chart for RVP
  • Previous Close 0.7499
  • Open 0.7500
  • Bid 0.7115 x 900
  • Ask 0.7400 x 1400
  • Day's Range 0.7110 - 0.7500
  • 52 Week Range 0.5600 - 1.2200
  • Volume 26,878
  • Avg. Volume 41,252
  • Market Cap (intraday) 21.285M
  • Beta (5Y Monthly) 1.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4000
  • Earnings Date Aug 12, 2025 - Aug 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

www.retractable.com

221

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RVP

View More

Performance Overview: RVP

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RVP
3.04%
S&P 500 (^GSPC)
1.00%

1-Year Return

RVP
21.87%
S&P 500 (^GSPC)
11.91%

3-Year Return

RVP
81.86%
S&P 500 (^GSPC)
52.27%

5-Year Return

RVP
85.75%
S&P 500 (^GSPC)
99.91%

Compare To: RVP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RVP

View More

Valuation Measures

Annual
As of 5/19/2025
  • Market Cap

    22.45M

  • Enterprise Value

    -20.65M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.68

  • Price/Book (mrq)

    0.26

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -35.97%

  • Return on Assets (ttm)

    -7.75%

  • Return on Equity (ttm)

    -12.75%

  • Revenue (ttm)

    33.05M

  • Net Income Avi to Common (ttm)

    -12.12M

  • Diluted EPS (ttm)

    -0.4000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    44.56M

  • Total Debt/Equity (mrq)

    1.41%

  • Levered Free Cash Flow (ttm)

    -6.11M

Research Analysis: RVP

View More

Company Insights: RVP

Research Reports: RVP

View More

People Also Watch